Text of subsection effective until April 01, 2025

(a) In this section, “board” means the Drug Utilization Review Board.

Text of subsection effective until April 01, 2025

(b) In addition to performing any other duties required by federal law, the board shall:
(1) develop and submit to the commission recommendations for preferred drug lists adopted by the commission under § 531.072;
(2) suggest to the commission restrictions or clinical edits on prescription drugs;
(3) recommend to the commission educational interventions for Medicaid providers;
(4) review drug utilization across Medicaid; and
(5) perform other duties that may be specified by law and otherwise make recommendations to the commission.